The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivo

Biomaterials

Volumn 31, Issue 26, 2010, Pages 6692-6700

  Praetner, Marc ^a   Rehberg, Markus ^a   Bihari, Peter ^a   Lerchenberger, Max ^a   Uhl, Bernd ^a   Holzer, Martin ^a   Eichhorn, Martin E ^a   Fürst, Robert ^b   Perisic, Tamara ^a   Reichel, Christoph A ^a   Welsch, Ulrich ^b   Krombach, Fritz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Blood kinetics; In vivo microscopy; Microcirculation; Nanoparticles; Quantum dots; Surface modifications

Indexed keywords

BLOOD KINETICS; IN VIVO MICROSCOPY; IN-VIVO; QUANTUM DOT; SURFACE MODIFICATION;

BLOOD; COATINGS; CONFOCAL MICROSCOPY; DYES; ENDOTHELIAL CELLS; FLOW CYTOMETRY; MICROCIRCULATION; MUSCLE; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SEMICONDUCTOR QUANTUM DOTS; TRANSMISSION ELECTRON MICROSCOPY;

SCANNING ELECTRON MICROSCOPY;

AMINE; ANION; CARBOXYL GROUP; CATION; MACROGOL; NANOCOATING; QUANTUM DOT;

ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; BLOOD SAMPLING; C57BL 6 MOUSE; CAPILLARY ENDOTHELIUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CREMASTER MUSCLE; FLOW CYTOMETRY; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROCIRCULATION; MICROSCOPY; MOLECULAR INTERACTION; MOUSE; MULTIPHOTON MICROSCOPY; NONHUMAN; PHAGOCYTOSIS; PLASMA CLEARANCE; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; C57BL MOUSE; CYTOLOGY; ENDOTHELIUM CELL; HEMODYNAMICS; INTRAARTERIAL DRUG ADMINISTRATION; KINETICS; METABOLISM; MICROVASCULATURE; PHOTON; TISSUE DISTRIBUTION; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ANIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; INJECTIONS, INTRA-ARTERIAL; KINETICS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY; MICROVESSELS; MUSCLE, SKELETAL; MYOCARDIUM; PHOTONS; QUANTUM DOTS; TISSUE DISTRIBUTION;

MUS;

EID: 77954384023     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.05.051     Document Type: Article

References (43)

1. Biju V., Itoh T., Anas A., Sujith A., Ishikawa M. Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications. Anal Bioanal Chem 2008, 391:2469-2495.
2. Cao Y.C. Nanomaterials for biomedical applications. Nanomed 2008, 3:467-469.
3. Medintz I.L., Mattoussi H., Clapp A.R. Potential clinical applications of quantum dots. Int J Nanomedicine 2008, 3:151-167.
4. Hsieh J.M., Ho M.L., Wu P.W., Chou P.T., Tsai T.T., Chi Y. Iridium-complex modified CdSe/ZnS quantum dots; a conceptual design for bi-functionality toward imaging and photosensitization. Chem Commun (Camb) 2006, 615-617.
5. Yaghini E., Seifalian A.M., MacRobert A.J. Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. Nanomed 2009, 4:353-363.
6. Orndorff R.L., Rosenthal S.J. Neurotoxin quantum dot conjugates detect endogenous targets expressed in live cancer cells. Nano Lett 2009, 9:2589-2599.
7. Wei Y., Jana N.R., Tan S.J., Ying J.Y. Surface coating directed cellular delivery of TAT-functionalized quantum dots. Bioconjug Chem 2009, 20:1752-1758.
8. Allen P.M., Liu W., Chauhan V.P., Lee J., Ting A.Y., Fukumura D., et al. In As(ZnCdS) quantum dots optimized for biological imaging in the near-infrared. J Am Chem Soc 2010, 132:470-471.
9. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004, 22:93-97.
10. Kobayashi H., Ogawa M., Kosaka N., Choyke P.L., Urano Y. Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents. Nanomed 2009, 4:411-419.
11. Lee P.W., Hsu S.H., Tsai J.S., Chen F.R., Huang P.J., Ke C.J., et al. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials 2010, 31:2425-2434.
12. Rhyner M.N., Smith A.M., Gao X., Mao H., Yang L., Nie S. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomed 2006, 1:209-217.
13. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharmacol 2008, 5:505-515.
14. Semmler-Behnke M., Kreyling W.G., Lipka J., Fertsch S., Wenk A., Takenaka S., et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008, 4:2108-2111.
15. Tartis M.S., Kruse D.E., Zheng H., Zhang H., Kheirolomoom A., Marik J., et al. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J Control Release 2008, 131:160-166.
16. Fischer H.C., Liu L., Pang K.S., Chan W.C.W. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat. Adv Funct Mat 2006, 16:1299-1305.
17. Kennel S.J., Woodward J.D., Rondinone A.J., Wall J., Huang Y., Mirzadeh S. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo. Nucl Med Biol 2008, 35:501-514.
18. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004, 15:79-86.
19. Choi H.S., Ipe B.I., Misra P., Lee J.H., Bawendi M.G., Frangioni J.V. Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett 2009, 9:2354-2359.
20. Daou T.J., Li L., Reiss P., Josserand V., Texier I. Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots. Langmuir 2009, 25:3040-3044.
21. Ballou B., Ernst L.A., Andreko S., Fitzpatrick J.A., Lagerholm B.C., Waggoner A.S., et al. Imaging vasculature and lymphatic flow in mice using quantum dots. Methods Mol Biol 2009, 574:63-74.
22. Larson D.R., Zipfel W.R., Williams R.M., Clark S.W., Bruchez M.P., Wise F.W., et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003, 300:1434-1436.
23. Pelley J.L., Daar A.S., Saner M.A. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci 2009, 112:276-296.
24. Stroh M., Zimmer J.P., Duda D.G., Levchenko T.S., Cohen K.S., Brown E.B., et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med 2005, 11:678-682.
25. Bihari P., Holzer M., Praetner M., Fent J., Lerchenberger M., Reichel C.A., et al. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. Toxicology 2010, 269:148-154.
26. Gentile F., Curcio A., Indolfi C., Ferrari M., Decuzzi P. The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnology 2008, 6:9.
27. Lee S.Y., Ferrari M., Decuzzi P. Design of bio-mimetic particles with enhanced vascular interaction. J Biomech 2009, 42:1885-1890.
28. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 1973, 5:384-394.
29. Mempel T.R., Moser C., Hutter J., Kuebler W.M., Krombach F. Visualization of leukocyte transendothelial and interstitial migration using reflected light oblique transillumination in intravital video microscopy. J Vasc Res 2003, 40:435-441.
30. Robe A., Pic E., Lassalle H.P., Bezdetnaya L., Guillemin F., Marchal F. Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice. BMC Cancer 2008, 8:111.
31. Bateman R.M., Hodgson K.C., Kohli K., Knight D., Walley K.R. Endotoxemia increases the clearance of mPEGylated 5000-MW quantum dots as revealed by multiphoton microvascular imaging. J Biomed Opt 2007, 12:064005.
32. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
33. Geys J., Nemmar A., Verbeken E., Smolders E., Ratoi M., Hoylaerts M.F., et al. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect 2008, 116:1607-1613.
34. Zhang L.W., Monteiro-Riviere N.A. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci 2009, 110:138-155.
35. Schipper M.L., Iyer G., Koh A.L., Cheng Z., Ebenstein Y., Aharoni A., et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009, 5:126-134.
36. Peracchia M.T., Harnisch S., Pinto-Alphandary H., Gulik A., Dedieu J.C., Desmaele D., et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials 1999, 20:1269-1275.
37. Owens D.E., Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006, 307:93-102.
38. Lee H.A., Imran M., Monteiro-Riviere N.A., Colvin V.L., Yu W.W., Riviere J.E. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Lett 2007, 7:2865-2870.
39. Fisher N.G., Christiansen J.P., Klibanov A., Taylor R.P., Kaul S., Lindner J.R. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 2002, 40:811-819.
40. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett 2007, 7:1344-1348.
41. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol 2007, 127:143-153.
42. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690.
43. Hellstrand E., Lynch I., Andersson A., Drakenberg T., Dahlback B., Dawson K.A., et al. Complete high-density lipoproteins in nanoparticle corona. FEBS J 2009, 276:3372-3381.